The invention relates to an anti- inflammatory composltwn compring: 53 wt.-% maltodextrin in relation to the total weight; IO - 12 wt.-% zinc oxide as a thixotropic agent; 1.8 wt.-% maltose; 0.0002 wt.-% sodium; 0.0002 wt.-% potassium; 0.0002 wt.-calcium; 0.0002 wt.-% phosphor; and 0.0006 wt.-% magnesium. The composition has an application viscosity in the range of 12,000-33,000 cp, a pH of between 5.6 and 6.9, a TGA of 61.12 and bond strength at 24 hours of 6 MPa.